Lantern Pharma Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lantern Pharma Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2020 to Q2 2024.
  • Lantern Pharma Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 10.8M shares, a 0.96% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 10.8M -104K -0.96% Aug 5, 2024 10-Q 2024-08-08
Q1 2024 10.7M -116K -1.07% Mar 5, 2024 10-K 2024-03-18
Q3 2023 10.9M +12K +0.11% Nov 3, 2023 10-Q 2023-11-08
Q2 2023 10.9M +38.1K +0.35% Aug 2, 2023 10-Q 2023-08-09
Q1 2023 10.9M +26.1K +0.24% Mar 6, 2023 10-K 2023-03-20
Q3 2022 10.9M -331K -2.96% Nov 1, 2022 10-Q 2022-11-07
Q2 2022 10.8M -353K -3.16% Aug 1, 2022 10-Q 2022-08-08
Q1 2022 10.8M -339K -3.03% Apr 28, 2022 10-Q 2022-05-03
Q3 2021 11.2M +4.97M +79.9% Oct 29, 2021 10-Q 2021-11-01
Q2 2021 11.2M +4.97M +79.9% Jul 22, 2021 10-Q 2021-07-29
Q1 2021 11.2M Mar 8, 2021 10-K 2021-03-10
Q3 2020 6.22M Oct 28, 2020 10-Q 2020-10-29
Q2 2020 6.22M Jul 29, 2020 10-Q 2020-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.